DCF — CHESHIRE MEDICAL CENTER
Enterprise Value: $-208.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-208.9M
Enterprise Value
$-69.9M
PV of Cash Flows
$-139.0M
PV of Terminal Value
$-223.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $243.3M | $-10.9M | -5.0% | $-21.2M | $-19.3M |
| Year 2 | $250.6M | $-8.8M | -4.0% | $-19.4M | $-16.0M |
| Year 3 | $258.1M | $-6.5M | -3.0% | $-17.4M | $-13.1M |
| Year 4 | $265.9M | $-5.3M | -2.0% | $-16.6M | $-11.3M |
| Year 5 | $273.8M | $-4.8M | -2.0% | $-16.4M | $-10.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-208.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$236.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5